EP4215175A1 - Oral retention device and preparation method therefor - Google Patents
Oral retention device and preparation method therefor Download PDFInfo
- Publication number
- EP4215175A1 EP4215175A1 EP21868727.5A EP21868727A EP4215175A1 EP 4215175 A1 EP4215175 A1 EP 4215175A1 EP 21868727 A EP21868727 A EP 21868727A EP 4215175 A1 EP4215175 A1 EP 4215175A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tablet
- teeth
- oral
- retention device
- ring body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000014759 maintenance of location Effects 0.000 title claims abstract description 80
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 210000000214 mouth Anatomy 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 25
- 238000010146 3D printing Methods 0.000 claims abstract description 15
- 238000001746 injection moulding Methods 0.000 claims abstract description 13
- 238000000465 moulding Methods 0.000 claims abstract description 11
- 210000004283 incisor Anatomy 0.000 claims description 28
- 238000003780 insertion Methods 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 24
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical class [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 15
- -1 polypropylene Polymers 0.000 claims description 11
- 230000003204 osmotic effect Effects 0.000 claims description 9
- 238000007639 printing Methods 0.000 claims description 9
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 claims description 8
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims description 8
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 8
- 229960004205 carbidopa Drugs 0.000 claims description 8
- TZFNLOMSOLWIDK-JTQLQIEISA-N carbidopa (anhydrous) Chemical compound NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-JTQLQIEISA-N 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims description 8
- 229960004502 levodopa Drugs 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 210000004357 third molar Anatomy 0.000 claims description 6
- 239000010440 gypsum Substances 0.000 claims description 5
- 229910052602 gypsum Inorganic materials 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 claims description 4
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 claims description 4
- 229960004150 aciclovir Drugs 0.000 claims description 4
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 4
- 229960000794 baclofen Drugs 0.000 claims description 4
- 229960002870 gabapentin Drugs 0.000 claims description 4
- 229960002963 ganciclovir Drugs 0.000 claims description 4
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 claims description 4
- 210000004373 mandible Anatomy 0.000 claims description 4
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims description 4
- 229960003105 metformin Drugs 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- 239000004632 polycaprolactone Substances 0.000 claims description 4
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 4
- 229940093257 valacyclovir Drugs 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- 238000000149 argon plasma sintering Methods 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000000602 vitallium Substances 0.000 claims description 3
- 229920001967 Metal rubber Polymers 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 2
- 229920001903 high density polyethylene Polymers 0.000 claims description 2
- 239000004700 high-density polyethylene Substances 0.000 claims description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 239000010970 precious metal Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 12
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 5
- 230000007774 longterm Effects 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000013267 controlled drug release Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 206010003497 Asphyxia Diseases 0.000 description 1
- 241000719491 Baldwinella eos Species 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000000033 corpus adiposum buccae Anatomy 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0092—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine for holding medicines in, or fixing medicines on, a tooth, e.g. holder containing medicines fixed on a tooth
Definitions
- the present disclosure relates to the field of medical devices, and in particular to an oral retention device and a preparation method therefor.
- APIs active pharmaceutical ingredients
- LD levodopa
- CD carbidopa
- baclofen acyclovir
- valaciclovir valaciclovir
- ganciclovir metformin
- gabapentin etc.
- Patent application US 10/668,274 and patent application CN 1997421 A disclosed an oral drug container based on an electrically controlled drug release mechanism, by which the drug release is electrically controlled, and insertion of medicinal tablets is not involved. Moreover, the drug container and the electric control system claimed in this patent are difficult to implement. There is no example in the patent specification, and it does not explain how to realize, based on the mechanism of electrically controlled drug release, the controlled release of an osmotic pump tablet as a drug storage device to achieve the drug absorption at the upper gastrointestinal tract, thereby achieving the long-term stable blood concentration.
- CN 1925823 A discloses a dental bracket by which a fluoride pellet is attached to the teeth to improve the treatment and/or prevention of dental caries.
- This patent application neither involves the drug absorption at the upper gastrointestinal tract and the long-term stable blood concentration, nor does it involve the way of insertion of medicinal tablets.
- Chinese Patent Application No. CN 105873631 A discloses an oral retention device that uses an electronic pump or a mechanical pump as an external power for drug delivery, which does not involve the insertion method of medicinal tablets.
- the medicinal tablet By means of inserting a medicinal tablet from the front to the back (in a direction from the incisors to the molars), the medicinal tablet is easy to slip off from the front of the device (the incisor side), and the patient is likely to suffocate due to accidentally swallowing the dropped medicinal tablet.
- the present disclosure provides a new oral retention device that retains a medicinal tablet in oral cavity that is not easy to drop out.
- the present disclosure provides an oral retention device, with a medicinal tablet being inserted in a way from back to front such that, because the back side of the device is close to the throat, and due to blocking by the oral tissues, such as the buccal fat pad tip and the pterygomandibular folds, the medicinal tablet will not easily drop out from the device in oral cavity, which will not cause suffocation due to accidental swallowing.
- a first aspect of the present disclosure provides an oral retention device, comprising a teeth-fitting component and a tablet-holding component.
- the teeth-fitting component is connected to the tablet-holding component, wherein the teeth-fitting component is used to bridge teeth in oral cavity with the tablet-holding component that can hold at least one medicinal tablet.
- the oral retention device is used to retain the medicinal tablet in oral cavity.
- the teeth-fitting component and the tablet-holding component are connected on respective sides; and/or the tablet-holding component has a reticular structure or a non-reticular structure, and the tablet-holding component has cross section in the shape of a circular, elliptical, polygonal, or special-shaped closed ring or open ring structure or a combination thereof.
- the cross section is a cross section perpendicular to a direction of the long axis of the teeth-fitting component (the direction of the long axis of the teeth-fitting component is substantially equivalent to the horizontal plane formed after matching of the teeth-fitting component and the teeth in oral cavity).
- the tablet-holding component comprises at least one ring body and at least one retainer, or the tablet-holding component is constituted by at least one retainer; wherein the ring body has an opening for insertion of a medicinal tablet, and the retainer has a structure for limiting the medicinal tablet in the tablet-holding component.
- the opening faces the molars in a horizontal direction formed by the molars and the incisors, and is used to enable the medicinal tablet to be inserted from the molars toward the incisors in the horizontal direction; or the opening is provided in a direction perpendicular to the horizontal direction such that the medicinal tablet is inserted down from the above in the direction perpendicular to the horizontal direction; or the opening faces the buccal side in a direction perpendicular to the horizontal direction such that the medicinal tablet is inserted from the buccal side to the lingual side in the direction perpendicular to the horizontal direction.
- the horizontal direction herein is substantially equivalent to the horizontal direction in which the longest axis of the teeth-fitting component is located when the oral retention device is placed horizontally, and is also substantially equivalent to the horizontal direction in which the oral retention device and the longest axis of the teeth-fitting component are located after the oral retention device matches with the teeth in oral cavity of the subject via the teeth-fitting component.
- the form of the medicinal tablet of the present disclosure does not change with time
- the medicinal tablet is an osmotic pump tablet.
- the osmotic pump tablet contains an active pharmaceutical ingredient and excipients.
- the active pharmaceutical ingredient is one of levodopa or its ester, carbidopa, baclofen, acyclovir, valaciclovir, ganciclovir, metformin, and gabapentin, or one or two of levodopa or its ester and carbidopa.
- the medicinal tablet is a membrane-controlled medicinal tablet, wherein the controlled-release membrane is made of water-insoluble cellulose acetate excipients, and the tablet core is supported by matrix composed of insoluble excipients or the push layer, and after the active pharmaceutical ingredient is completely released from the medicinal tablet in oral cavity, the apperance of the medicinal tablet is still a complete tablet shape.
- the ring body is an open ring body or a closed ring body.
- the closed ring body is a circular, elliptical, polygonal, or special-shaped closed ring body; and the open ring body is a circular, elliptical, polygonal, or special-shaped open ring body with part thereof missing (non-closed).
- the retainer is of a circular arc hollow or solid shape, or the retainer is formed by connecting a closed ring body and a semicircular part perpendicular to the closed ring body; and/or the retainer abuts with the ring body, or the retainer and the ring body are arranged at an interval.
- the retainer and the ring body are abutted by means of integral molding or are connected together by a connecting structure.
- the retainer is provided as one retainer that is located on the incisor side in the horizontal direction; and/or the ring body is provided as one ring body that is located on the molar side in the horizontal direction formed by the molars and the incisors.
- the teeth-fitting component can match with any one or more teeth in oral cavity, and/or the teeth-fitting component has a length equal to the length of 2-5 teeth.
- the teeth are mandibular permanent teeth.
- they are mandibular molars.
- they are the first molar and the second molar, or are the first molar, the second molar and the second premolar, or are the first molar, the second molar and the third molar, or are the first molar, the second molar, the third molar and the second premolar.
- the teeth-fitting component is prepared according to the size and shape of the individual teeth.
- the teeth-fitting component is wrapped, embedded, fitted, or inserted into the teeth that matches with the teeth-fitting component.
- the material of the oral retention device is an oral stable material, which is selected from oral stable metal or thermoplastic elastomer.
- the oral stable metal is selected from one of titanium, stainless steel, cobalt-chromium alloy, cobalt-chromium-molybdenum alloy or precious metal for dental use; and the thermoplastic elastomer is selected from copolymers of one or two of polycaprolactone, ethylene-vinyl acetate copolymer, high-density polyethylene, polypropylene, polyacrylate, polyurethane, silicon polymer, polyester, poly(styrene-ethylene-butylene-styrene), poly(styrene-butadiene-styrene), and poly(styreneisoprene-styrene).
- the materials of the teeth-fitting component and the tablet-holding component are cobalt-chromium alloy.
- a second aspect of the present disclosure provides a method for preparing the oral retention device according to the first aspect of the present disclosure.
- the method being selected from any one of 3D printing, injection molding or impression molding.
- the method for preparing the oral retention device according to the first aspect of the present disclosure is 3D printing, comprising the following steps:
- a "3 Shape TRIOS ® " intraoral scanner is used to scan the data of size of a medicinal tablet, the data is then imported into the software "SolidWorks", a plan of a tablet-holding component that can load the tablet is designed, and the plan is created and saved as a "standard attachment”;
- the "3Shape TRIOS ® " intraoral scanner is used to scan the teeth of the subject, the data is imported into the software "3 Shape Dental System”, and a teeth-fitting component is designed according to the data of teeth;
- the “standard attachment” is added and assembled with the teeth-fitting component to form an integrated oral retention device, and a 3D printable file is exported; and the 3D printable file is imported into the 3D printer, and the oral retention device is printed.
- the 3D printing preferably uses a laser sintering process.
- the operating principle of the 3D printing is substantially the same as that of an ordinary printer.
- the 3D printer is internally loaded with different "printing materials", such as metal, ceramic, plastic, and sand, and after the printer is connected to a computer, the "printing material” can be controlled to be stacked layer by layer, and finally the blueprint on the computer is turned into a real object.
- 3D printing refers to the technical principles of ordinary printers.
- the layered processing procedure is very similar to inkjet printing. This printing technology is referred to as 3D stereoscopic printing technology. There are many different techniques for printing 3D, which differ in the way they are available and build components at different levels.
- the 3D printing materials commonly used include nylon, glass fiber, polylactic acid, ABS resin, durable nylon materials, gypsum materials, aluminum materials, metallic titanium, titanium alloy, stainless steel, silver-plated materials, gold-plated materials, cobalt-chromium alloy, cobalt-chromium-molybdenum alloy, or rubber materials, etc.
- 3D printing is advantageous in that the automated operation can be implemented, the production speed is fast, the design blueprint in the computer can be directly and accurately converted into a physical model, and it is also suitable for small-scale custom manufacturing.
- the method for preparing the oral retention device according to the first aspect of the present disclosure is injection molding, comprising the following steps:
- Injection molding is also referred to as injection modeling, and is a method of injection combined with molding, that is, a method in which at a certain temperature, the completely melted material is stirred by a screw, then injected into a mold cavity at high pressure, and cooled and cured to obtain a molded product.
- the method is suitable for mass production of parts with complex shapes and is one of the important processing methods.
- the injection molding method is advantageous in that the production speed is fast, the efficiency is high, automated operation can be implemented, the produced articles have a variety of colors, various shapes from simple to complex, various sizes from large to small, and precise size, and the products are easy to upgrade and can be made into parts with complex shapes.
- Injection molding is suitable for the fields of mass production and molding processing for products with complex shapes.
- the method for preparing the oral retention device according to the first aspect of the present disclosure is impression molding, comprising:
- a tablet-holding component capable of loading an osmotic pump tablet is prepared by means of a traditional injection molding process; and then a thermoplastic sheet is heated and softened to prepare a teeth-fitting component, and at the same time the softened teeth-fitting component is fitted with the tablet-holding component in an embedded manner and is then cooled to form an integrated oral retention device, which is taken out of oral cavity.
- Reagents and raw materials used in the present disclosure are all commercially available.
- the positive effect of the present disclosure lies in: providing an oral retention device, with a medicinal tablet being inserted in a direction from the throat to the incisors such that, because the back side of the oral retention device is close to the throat, and due to blocking by the oral mucosal tissues, the medicinal tablet will not drop out in oral cavity.
- the medicinal tablet is inserted into the oral retention device to form a drug-device combination, which is fixed on the matching teeth in oral cavity, implementing sustained release of the drug within a certain period of time. After being retained for 0-24 hours, the drug-device combination is taken out, replaced with a new medicinal tablet, and re-fixed on the matching teeth in oral cavity, so as to continuously and stably release the drug.
- the oral retention device with a medicinal tablet being inserted from the back is composed of a teeth-fitting component 11 and a tablet-holding component 41 connected to each other.
- the teeth-fitting component 11 can be closely attached to the teeth in oral cavity of the subject, and the tablet-holding component 41 is sized to hold at least one medicinal tablet and retain the medicinal tablet in oral cavity.
- Both the teeth-fitting component 11 and the tablet-holding component 41 are made of cobalt-chromium alloy, and the teeth-fitting component 11 and the tablet-holding component 41 are connected on respective sides.
- the tablet-holding component comprises a ring body 31 and a retainer 21 that is located at the end.
- the ring body 31 is a circular closed ring body with an opening 311 for insertion of a medicinal tablet.
- the retainer and the ring body are arranged at an interval, and are respectively connected to the teeth-fitting component 11.
- the retainer may be integrally formed with the ring body and then fixed on the teeth-fitting component, and may also be integrally formed with the ring body and the teeth-fitting component.
- the opening 311 opens toward the molars in the horizontal direction formed by the molars and the incisors (the ring body 31 is located on the molar side in the horizontal direction, that is, the position of the ring body 31 is closer to the molars than the position of the retainer 21), and the medicinal tablet is inserted from the molars toward the incisors in the horizontal direction.
- the retainer is of a circular arc hollow shape, and has a structure configured to limit the medicinal tablet in the tablet-holding component.
- the teeth-fitting component 11 matches the first molar, the second molar and/or the third molar on the mandible in oral cavity of the subject, and wraps the teeth by means of matching.
- the oral retention device loaded with a medicinal tablet according to this embodiment in oral cavity, even if the immediate release layer of the drug is quickly dissolved after intensive gargle, the medicinal tablet can be firmly secured and will not slip off the device.
- the oral retention device with a medicinal tablet being inserted from the front is composed of a teeth-fitting component 12 and a tablet-holding component 42 connected to each other.
- the teeth-fitting component 12 can be closely attached to the teeth in oral cavity of the subject, and the tablet-holding component 42 is sized to hold at least one medicinal tablet and retain the medicinal tablet in oral cavity.
- Both the teeth-fitting component 12 and the tablet-holding component 42 are made of cobalt-chromium alloy, and the teeth-fitting component 12 and the tablet-holding component 42 are connected on respective sides.
- the tablet-holding component 42 comprises a ring body 32 and a retainer 22 that is located at the end.
- the ring body 32 is a circular closed ring body with an opening 321 for insertion of a medicinal tablet.
- the retainer and the ring body are arranged at an interval, and are respectively connected to the teeth-fitting component 11.
- the retainer may be integrally formed with the ring body and then fixed on the teeth-fitting component, and may also be integrally formed with the ring body and the teeth-fitting component.
- the opening 321 opens toward the incisors in the horizontal direction formed by the molars and the incisors (the ring body 32 is located on the molar side in the horizontal direction formed by the molars and the incisors, that is, the position of the ring body 32 is closer to the incisors than the position of the retainer 22), and the medicinal tablet is inserted from the incisors toward the molars in the horizontal direction formed by the molars and the incisors.
- the retainer is of a circular arc hollow shape, and the retainer has a structure configured to limit the medicinal tablet in the tablet-holding component.
- the teeth-fitting component 11 matches the first molar, the second molar and/or the third molar on the mandible in oral cavity of the subject, and wraps the teeth by means of matching.
- the medicinal tablet may slip off the device during the rapid dissolution of the immediate release layer of the drug after intensive gargle, and may slip off the device during the wearing, but still has a certain use value.
- the cobalt-chromium alloy back-insertion oral retention device prepared according to this embodiment comprises a teeth-fitting component 11 and a tablet-holding component.
- the teeth-fitting component 11 and the tablet-holding component are connected on respective sides, the teeth-fitting component can be closely attached to teeth in oral cavity, and the tablet-holding component can hold at least one medicinal tablet and retain the medicinal tablet in oral cavity.
- the medicinal tablet may be a controlled-release preparation, preferably an osmotic pump tablet.
- the osmotic pump tablet contains an active pharmaceutical ingredient and excipients.
- the active pharmaceutical ingredient includes levodopa or its ester, carbidopa, baclofen, acyclovir, valaciclovir, ganciclovir, metformin, and gabapentin, or one or two of levodopa or its ester and carbidopa.
- the tablet-holding component has a cross section in the shape of a circular closed loop.
- the tablet-holding component may have a reticular structure or a non-reticular structure.
- the tablet-holding component comprises at least one ring body 31 and at least one retainer 21 that is located at the end, and the ring body 31 forms an opening 311 for insertion of a medicinal tablet.
- the retainer is of a circular arc hollow shape. The opening faces the molars in the horizontal direction formed by the molars and the incisors, and the medicinal tablet is inserted from the molars toward the incisors in the horizontal direction.
- a dental gypsum model of a patient/volunteer is prepared by means of the traditional model-taking technology; then, by means of a traditional manual process, with dental wax as the material, a dental wax model is manually prepared based on the gypsum model; and finally, with cobalt-chromium porcelain alloy as the material, the oral retention device is prepared by means of a traditional injection molding process.
- Example 5 Cobalt-chromium alloy front-insertion oral retention device prepared by means of 3D printing
- the oral retention device as shown in Fig. 2 is prepared by the same method as Example 3, only different in the f in step 3, the positions of the ring body and the retainer of the tablet-holding component are opposite to those in Example 3.
- the ring body 32 of the tablet-holding component 42 forms an opening 321 for insertion of a medicinal tablet, the opening opens toward the incisors in the horizontal direction formed by the molars and the incisors, and the medicinal tablet is inserted from the incisors to the molars in the horizontal direction.
- the medicinal tablet may be a controlled-release preparation, preferably an osmotic pump tablet.
Abstract
Description
- The present disclosure relates to the field of medical devices, and in particular to an oral retention device and a preparation method therefor.
- Many active pharmaceutical ingredients (APIs) , including levodopa (LD) or its ester, carbidopa (CD), baclofen, acyclovir, valaciclovir, ganciclovir, metformin, gabapentin, etc., have their absorption window limited at the upper gastrointestinal tract. Incorporation of such APIs into conventional extended release dosages will not only result in reduced bioavailability, but also leads to failure of achieving extended therapeutic coverage. Many techniques have been disclosed in the prior art to prolong the retention time of the active pharmaceutical ingredients in the stomach. These techniques include expansion (
US 4,735,804 ,US 5,002,772 ,US 6,685,962 , etc.), swelling (US 4,434,153 ,US 5,750,585 ,US 5,972,389 ,US 6,120,803 ,US 6,660,300 B1 ,US 2007/0196396 A1 ,US 9,439,851 US 4,167,558 ,US 5,232,704 ,US 6,261,601 , etc.), raft-forming (US 4,140,760 ,US 5,068,109 , etc.), subsidence (US 4,193,985 ,US 4,900,557 , etc.), and muco-adhesion (US 6,207,197 ,US 11/204,106 - Therefore, there is a need for a new drug-controlled release system that can provide long-term exposure to these active pharmaceutical ingredients with their absorption window limited at the upper gastrointestinal tract. The oral retention device and these APIs are combined to form a drug-device combination to form an oral retention drug delivery system, which can provide long-term exposure to these APIs with their absorption window limited at the upper gastrointestinal tract.
- At present, there are limited related research on oral retention devices. Patent application
US 10/668,274 CN 1997421 A disclosed an oral drug container based on an electrically controlled drug release mechanism, by which the drug release is electrically controlled, and insertion of medicinal tablets is not involved. Moreover, the drug container and the electric control system claimed in this patent are difficult to implement. There is no example in the patent specification, and it does not explain how to realize, based on the mechanism of electrically controlled drug release, the controlled release of an osmotic pump tablet as a drug storage device to achieve the drug absorption at the upper gastrointestinal tract, thereby achieving the long-term stable blood concentration. - In addition,
CN 1925823 A discloses a dental bracket by which a fluoride pellet is attached to the teeth to improve the treatment and/or prevention of dental caries. This patent application neither involves the drug absorption at the upper gastrointestinal tract and the long-term stable blood concentration, nor does it involve the way of insertion of medicinal tablets. - In addition, Chinese Patent Application No.
CN 105873631 A discloses an oral retention device that uses an electronic pump or a mechanical pump as an external power for drug delivery, which does not involve the insertion method of medicinal tablets. - By means of inserting a medicinal tablet from the front to the back (in a direction from the incisors to the molars), the medicinal tablet is easy to slip off from the front of the device (the incisor side), and the patient is likely to suffocate due to accidentally swallowing the dropped medicinal tablet.
- In order to solve the technical problem of the defect of low bioavailability due to the short residence time of the active pharmaceutical ingredients in the stomach, the present disclosure provides a new oral retention device that retains a medicinal tablet in oral cavity that is not easy to drop out. Specifically, the present disclosure provides an oral retention device, with a medicinal tablet being inserted in a way from back to front such that, because the back side of the device is close to the throat, and due to blocking by the oral tissues, such as the buccal fat pad tip and the pterygomandibular folds, the medicinal tablet will not easily drop out from the device in oral cavity, which will not cause suffocation due to accidental swallowing.
- A first aspect of the present disclosure provides an oral retention device, comprising a teeth-fitting component and a tablet-holding component. The teeth-fitting component is connected to the tablet-holding component, wherein the teeth-fitting component is used to bridge teeth in oral cavity with the tablet-holding component that can hold at least one medicinal tablet. The oral retention device is used to retain the medicinal tablet in oral cavity.
- In a preferable embodiment, the teeth-fitting component and the tablet-holding component are connected on respective sides; and/or the tablet-holding component has a reticular structure or a non-reticular structure, and the tablet-holding component has cross section in the shape of a circular, elliptical, polygonal, or special-shaped closed ring or open ring structure or a combination thereof. The cross section is a cross section perpendicular to a direction of the long axis of the teeth-fitting component (the direction of the long axis of the teeth-fitting component is substantially equivalent to the horizontal plane formed after matching of the teeth-fitting component and the teeth in oral cavity).
- In a preferable embodiment, the tablet-holding component comprises at least one ring body and at least one retainer, or the tablet-holding component is constituted by at least one retainer; wherein the ring body has an opening for insertion of a medicinal tablet, and the retainer has a structure for limiting the medicinal tablet in the tablet-holding component.
- In a preferable embodiment, the opening faces the molars in a horizontal direction formed by the molars and the incisors, and is used to enable the medicinal tablet to be inserted from the molars toward the incisors in the horizontal direction; or the opening is provided in a direction perpendicular to the horizontal direction such that the medicinal tablet is inserted down from the above in the direction perpendicular to the horizontal direction; or the opening faces the buccal side in a direction perpendicular to the horizontal direction such that the medicinal tablet is inserted from the buccal side to the lingual side in the direction perpendicular to the horizontal direction. The horizontal direction herein is substantially equivalent to the horizontal direction in which the longest axis of the teeth-fitting component is located when the oral retention device is placed horizontally, and is also substantially equivalent to the horizontal direction in which the oral retention device and the longest axis of the teeth-fitting component are located after the oral retention device matches with the teeth in oral cavity of the subject via the teeth-fitting component.
- Preferably, the form of the medicinal tablet of the present disclosure does not change with time, and the medicinal tablet is an osmotic pump tablet. In a preferable embodiment, the osmotic pump tablet contains an active pharmaceutical ingredient and excipients. The active pharmaceutical ingredient is one of levodopa or its ester, carbidopa, baclofen, acyclovir, valaciclovir, ganciclovir, metformin, and gabapentin, or one or two of levodopa or its ester and carbidopa. The medicinal tablet is a membrane-controlled medicinal tablet, wherein the controlled-release membrane is made of water-insoluble cellulose acetate excipients, and the tablet core is supported by matrix composed of insoluble excipients or the push layer, and after the active pharmaceutical ingredient is completely released from the medicinal tablet in oral cavity, the apperance of the medicinal tablet is still a complete tablet shape.
- Preferably, the ring body is an open ring body or a closed ring body.
- Preferably, the closed ring body is a circular, elliptical, polygonal, or special-shaped closed ring body; and the open ring body is a circular, elliptical, polygonal, or special-shaped open ring body with part thereof missing (non-closed).
- In a preferable embodiment, the retainer is of a circular arc hollow or solid shape, or the retainer is formed by connecting a closed ring body and a semicircular part perpendicular to the closed ring body; and/or the retainer abuts with the ring body, or the retainer and the ring body are arranged at an interval.
- Preferably, the retainer and the ring body are abutted by means of integral molding or are connected together by a connecting structure.
- In a preferable embodiment, the retainer is provided as one retainer that is located on the incisor side in the horizontal direction; and/or the ring body is provided as one ring body that is located on the molar side in the horizontal direction formed by the molars and the incisors.
- Preferably, the teeth-fitting component can match with any one or more teeth in oral cavity, and/or the teeth-fitting component has a length equal to the length of 2-5 teeth.
- Preferably, the teeth are mandibular permanent teeth. Preferably, they are mandibular molars. Most preferably, they are the first molar and the second molar, or are the first molar, the second molar and the second premolar, or are the first molar, the second molar and the third molar, or are the first molar, the second molar, the third molar and the second premolar.
- Preferably, the teeth-fitting component is prepared according to the size and shape of the individual teeth. The teeth-fitting component is wrapped, embedded, fitted, or inserted into the teeth that matches with the teeth-fitting component.
- Preferably, the material of the oral retention device is an oral stable material, which is selected from oral stable metal or thermoplastic elastomer.
- Preferably, the oral stable metal is selected from one of titanium, stainless steel, cobalt-chromium alloy, cobalt-chromium-molybdenum alloy or precious metal for dental use; and the thermoplastic elastomer is selected from copolymers of one or two of polycaprolactone, ethylene-vinyl acetate copolymer, high-density polyethylene, polypropylene, polyacrylate, polyurethane, silicon polymer, polyester, poly(styrene-ethylene-butylene-styrene), poly(styrene-butadiene-styrene), and poly(styreneisoprene-styrene).
- More preferably, the materials of the teeth-fitting component and the tablet-holding component are cobalt-chromium alloy.
- A second aspect of the present disclosure provides a method for preparing the oral retention device according to the first aspect of the present disclosure. The method being selected from any one of 3D printing, injection molding or impression molding.
- The method for preparing the oral retention device according to the first aspect of the present disclosure is 3D printing, comprising the following steps:
- (1) adding a saved tablet-holding component plan in design software, assembling the plan with a teeth-fitting component plan to form an integrated oral retention device plan, and exporting a 3D printable file; preferably the design software is 3Shape Dental System;
- (2) importing the 3D printable file into a 3D printer, and printing the oral retention device; wherein the 3D printing preferably uses a laser sintering process;
- preferably, before the step (1), the following steps are included: (0) designing the tablet-holding component plan according to the data of the size of the medicinal tablet in software, and saving the plan; preferably the software is Solidworks or ZWSOFT; and/or designing the teeth-fitting component plan according to the data of the size of teeth of the subject;
- more preferably, the data of the size of the medicinal tablet and/or the data of the teeth of the subject are obtained by means of scanning the tablet and/or the teeth of the subject or the dental model of the subject with a scanner, the dental model is prepared by traditional molding technique, and the scanner is preferably 3 Shape TRIOS® scanner.
- In a specific embodiment, a "3 Shape TRIOS®" intraoral scanner is used to scan the data of size of a medicinal tablet, the data is then imported into the software "SolidWorks", a plan of a tablet-holding component that can load the tablet is designed, and the plan is created and saved as a "standard attachment"; the "3Shape TRIOS®" intraoral scanner is used to scan the teeth of the subject, the data is imported into the software "3 Shape Dental System", and a teeth-fitting component is designed according to the data of teeth; on the software "3 Shape Dental System", the "standard attachment" is added and assembled with the teeth-fitting component to form an integrated oral retention device, and a 3D printable file is exported; and the 3D printable file is imported into the 3D printer, and the oral retention device is printed. The 3D printing preferably uses a laser sintering process.
- The operating principle of the 3D printing is substantially the same as that of an ordinary printer. The 3D printer is internally loaded with different "printing materials", such as metal, ceramic, plastic, and sand, and after the printer is connected to a computer, the "printing material" can be controlled to be stacked layer by layer, and finally the blueprint on the computer is turned into a real object. 3D printing refers to the technical principles of ordinary printers. The layered processing procedure is very similar to inkjet printing. This printing technology is referred to as 3D stereoscopic printing technology. There are many different techniques for printing 3D, which differ in the way they are available and build components at different levels. The 3D printing materials commonly used include nylon, glass fiber, polylactic acid, ABS resin, durable nylon materials, gypsum materials, aluminum materials, metallic titanium, titanium alloy, stainless steel, silver-plated materials, gold-plated materials, cobalt-chromium alloy, cobalt-chromium-molybdenum alloy, or rubber materials, etc. 3D printing is advantageous in that the automated operation can be implemented, the production speed is fast, the design blueprint in the computer can be directly and accurately converted into a physical model, and it is also suitable for small-scale custom manufacturing.
- In other embodiments, the method for preparing the oral retention device according to the first aspect of the present disclosure is injection molding, comprising the following steps:
- (1) preparing a teeth-fitting component model according to a dental model;
- (2) preparing a tablet-holding component model according to the size of the medicinal tablet;
- (3) obtaining an oral retention device model integrating the teeth-fitting component and the tablet-holding component;
- (4) preparing a personalized oral retention device by means of a traditional injection molding process, wherein
- preferably, the dental model is prepared by means of the traditional model-taking technology, or prepared by obtaining teeth data of a subject by means of the oral scanning technology and printing; and
- more preferably, the materials of the teeth-fitting component model, the tablet-holding component model and the oral retention device model are dental wax, and/or the material of the dental model is gypsum or resin.
- Injection molding is also referred to as injection modeling, and is a method of injection combined with molding, that is, a method in which at a certain temperature, the completely melted material is stirred by a screw, then injected into a mold cavity at high pressure, and cooled and cured to obtain a molded product. The method is suitable for mass production of parts with complex shapes and is one of the important processing methods. The injection molding method is advantageous in that the production speed is fast, the efficiency is high, automated operation can be implemented, the produced articles have a variety of colors, various shapes from simple to complex, various sizes from large to small, and precise size, and the products are easy to upgrade and can be made into parts with complex shapes. Injection molding is suitable for the fields of mass production and molding processing for products with complex shapes.
- In other embodiments, the method for preparing the oral retention device according to the first aspect of the present disclosure is impression molding, comprising:
- designing a tablet-holding component according to the size of the medicinal tablet;
- preparing the teeth-fitting component from polycaprolactone (PCL) as the material, and
- preparing the tablet-holding component from cobalt-chromium alloy as the material;
- and assembling the teeth-fitting component and the tablet-holding component into a complete oral retention device.
- In a specific embodiment, at first, a tablet-holding component capable of loading an osmotic pump tablet is prepared by means of a traditional injection molding process; and then a thermoplastic sheet is heated and softened to prepare a teeth-fitting component, and at the same time the softened teeth-fitting component is fitted with the tablet-holding component in an embedded manner and is then cooled to form an integrated oral retention device, which is taken out of oral cavity.
- On the basis of conforming common knowledge in the technical field, the above-mentioned various preferred conditions can be combined in any manner, such that various preferred examples of the present disclosure are obtained.
- Reagents and raw materials used in the present disclosure are all commercially available.
- The positive effect of the present disclosure lies in: providing an oral retention device, with a medicinal tablet being inserted in a direction from the throat to the incisors such that, because the back side of the oral retention device is close to the throat, and due to blocking by the oral mucosal tissues, the medicinal tablet will not drop out in oral cavity. The medicinal tablet is inserted into the oral retention device to form a drug-device combination, which is fixed on the matching teeth in oral cavity, implementing sustained release of the drug within a certain period of time. After being retained for 0-24 hours, the drug-device combination is taken out, replaced with a new medicinal tablet, and re-fixed on the matching teeth in oral cavity, so as to continuously and stably release the drug.
-
-
Fig. 1 is an oral retention device with a medicinal tablet being inserted from the back according to an embodiment of the present disclosure, the device being composed of a teeth-fittingcomponent 11 and a tablet-holdingcomponent 41, wherein the tablet-holdingcomponent 41 is composed of aretainer 21 and aring body 31, thering body 31 being provided with anopening 311. -
Fig. 2 is an oral retention device with a medicinal tablet being inserted from the front according to an embodiment of the present disclosure, the device being composed of a teeth-fittingcomponent 12 and a tablet-holdingcomponent 42, wherein the tablet-holdingcomponent 42 is composed of aretainer 22 and aring body 32, thering body 32 being provided with anopening 321. -
- 11: Teeth-fitting component of back-insertion oral retention device
- 21: Retainer of back-insertion oral retention device
- 31: Ring body of back-insertion oral retention device
- 311: Opening on ring body of back-insertion oral retention device
- 41: Tablet-holding component of back-insertion oral retention device
- 12: Teeth-fitting component of front-insertion oral retention device
- 22: Retainer of front-insertion oral retention device
- 32: Ring body of front-insertion oral retention device
- 321: Opening on ring body of front-insertion oral retention device
- 42: Tablet-holding component of front-insertion oral retention device
- The preferred embodiments will be listed below, and the present disclosure will be illustrated more clearly and completely in conjunction with the drawings. It should be noted that unless otherwise specified, the relative arrangement and numerical values of the parts and steps set forth in these embodiments do not limit the scope of the present disclosure.
- In the embodiment shown in
Fig. 1 , the oral retention device with a medicinal tablet being inserted from the back is composed of a teeth-fittingcomponent 11 and a tablet-holdingcomponent 41 connected to each other. The teeth-fittingcomponent 11 can be closely attached to the teeth in oral cavity of the subject, and the tablet-holdingcomponent 41 is sized to hold at least one medicinal tablet and retain the medicinal tablet in oral cavity. Both the teeth-fittingcomponent 11 and the tablet-holdingcomponent 41 are made of cobalt-chromium alloy, and the teeth-fittingcomponent 11 and the tablet-holdingcomponent 41 are connected on respective sides. The tablet-holding component comprises aring body 31 and aretainer 21 that is located at the end. Thering body 31 is a circular closed ring body with anopening 311 for insertion of a medicinal tablet. The retainer and the ring body are arranged at an interval, and are respectively connected to the teeth-fittingcomponent 11. In another solution, the retainer may be integrally formed with the ring body and then fixed on the teeth-fitting component, and may also be integrally formed with the ring body and the teeth-fitting component. After the oral retention device matches with the teeth in oral cavity of the subject via the teeth-fitting component, theopening 311 opens toward the molars in the horizontal direction formed by the molars and the incisors (thering body 31 is located on the molar side in the horizontal direction, that is, the position of thering body 31 is closer to the molars than the position of the retainer 21), and the medicinal tablet is inserted from the molars toward the incisors in the horizontal direction. The retainer is of a circular arc hollow shape, and has a structure configured to limit the medicinal tablet in the tablet-holding component. The teeth-fittingcomponent 11 matches the first molar, the second molar and/or the third molar on the mandible in oral cavity of the subject, and wraps the teeth by means of matching. - Wearing the oral retention device loaded with a medicinal tablet according to this embodiment in oral cavity, even if the immediate release layer of the drug is quickly dissolved after intensive gargle, the medicinal tablet can be firmly secured and will not slip off the device.
- In the embodiment shown in
Fig. 2 , the oral retention device with a medicinal tablet being inserted from the front is composed of a teeth-fittingcomponent 12 and a tablet-holdingcomponent 42 connected to each other. The teeth-fittingcomponent 12 can be closely attached to the teeth in oral cavity of the subject, and the tablet-holdingcomponent 42 is sized to hold at least one medicinal tablet and retain the medicinal tablet in oral cavity. Both the teeth-fittingcomponent 12 and the tablet-holdingcomponent 42 are made of cobalt-chromium alloy, and the teeth-fittingcomponent 12 and the tablet-holdingcomponent 42 are connected on respective sides. The tablet-holdingcomponent 42 comprises aring body 32 and aretainer 22 that is located at the end. Thering body 32 is a circular closed ring body with anopening 321 for insertion of a medicinal tablet. The retainer and the ring body are arranged at an interval, and are respectively connected to the teeth-fittingcomponent 11. In another solution, the retainer may be integrally formed with the ring body and then fixed on the teeth-fitting component, and may also be integrally formed with the ring body and the teeth-fitting component. Theopening 321 opens toward the incisors in the horizontal direction formed by the molars and the incisors (thering body 32 is located on the molar side in the horizontal direction formed by the molars and the incisors, that is, the position of thering body 32 is closer to the incisors than the position of the retainer 22), and the medicinal tablet is inserted from the incisors toward the molars in the horizontal direction formed by the molars and the incisors. The retainer is of a circular arc hollow shape, and the retainer has a structure configured to limit the medicinal tablet in the tablet-holding component. The teeth-fittingcomponent 11 matches the first molar, the second molar and/or the third molar on the mandible in oral cavity of the subject, and wraps the teeth by means of matching. - Wearing the oral retention device loaded with a medicinal tablet according to this embodiment in oral cavity, the medicinal tablet may slip off the device during the rapid dissolution of the immediate release layer of the drug after intensive gargle, and may slip off the device during the wearing, but still has a certain use value.
- The method for preparing the cobalt-chromium alloy back-insertion oral retention device according to this embodiment comprises the following steps:
- step 1: obtaining the data of size of the medicinal tablet by scanning with a "3 Shape Dental System" scanner; then, with the software "SolidWorks", designing a tablet-holding component capable of loading the drug part, and creating and saving a "standard attachment"; and every time an oral retention device is designed in the software "3 Shape Dental System", adding the "standard attachment" and assembling same with the teeth-fitting component to form an integrated oral retention device;
- step 2: performing an intraoral or dental model scan:
- a. opening scanning software;
- b. creating a new patient file, and creating a new case file;
- c. choosing a research model;
- d. performing scanning on the mandible;
- e. performing scanning on the maxillary;
- f. performing scanning for the occlusal relationship;
- g. post-processing the files to confirm that the scanning data of all molars and premolars are complete and free of defects, and the accurate scanning of occlusion of upper and lower teeth is implemented; and
- h. saving 3OXZ or STL format files.
- step 3: designing the device
- a. opening a design software;
- b. creating a new order;
- c. selecting the position of tooth/teeth;
- d. choosing a basal crown design;
- e. importing the oral scanning teeth data (a STL file); designing personalized teeth-fitting component;
- f. adding the "standard attachment" and assembling with the teeth-fitting component to form an integrated oral retention device, in which the opening opens toward the molars in the horizontal direction formed by the molars and the incisors such that the medicinal tablet is located in the horizontal direction formed by the molars and the incisors and can be inserted from the molars toward the incisors; and
- g. after the design is completed, exporting a 3OXZ or STL format file; and
- step 4: performing 3D printing/in-place polishing/cleaning;
- a. inputting a CAM program;
- b. EOS laser casting;
- c. grinding and polishing, and the device is shown in
Figure 1 ; - d. cleaning;
- e. inspecting final product.
- As shown in
Fig. 1 , the cobalt-chromium alloy back-insertion oral retention device prepared according to this embodiment comprises a teeth-fittingcomponent 11 and a tablet-holding component. The teeth-fittingcomponent 11 and the tablet-holding component are connected on respective sides, the teeth-fitting component can be closely attached to teeth in oral cavity, and the tablet-holding component can hold at least one medicinal tablet and retain the medicinal tablet in oral cavity. The medicinal tablet may be a controlled-release preparation, preferably an osmotic pump tablet. The osmotic pump tablet contains an active pharmaceutical ingredient and excipients. The active pharmaceutical ingredient includes levodopa or its ester, carbidopa, baclofen, acyclovir, valaciclovir, ganciclovir, metformin, and gabapentin, or one or two of levodopa or its ester and carbidopa. The tablet-holding component has a cross section in the shape of a circular closed loop. The tablet-holding component may have a reticular structure or a non-reticular structure. The tablet-holding component comprises at least onering body 31 and at least oneretainer 21 that is located at the end, and thering body 31 forms anopening 311 for insertion of a medicinal tablet. The retainer is of a circular arc hollow shape. The opening faces the molars in the horizontal direction formed by the molars and the incisors, and the medicinal tablet is inserted from the molars toward the incisors in the horizontal direction. - At first, a dental gypsum model of a patient/volunteer is prepared by means of the traditional model-taking technology; then, by means of a traditional manual process, with dental wax as the material, a dental wax model is manually prepared based on the gypsum model; and finally, with cobalt-chromium porcelain alloy as the material, the oral retention device is prepared by means of a traditional injection molding process.
- The oral retention device as shown in
Fig. 2 is prepared by the same method as Example 3, only different in the f in step 3, the positions of the ring body and the retainer of the tablet-holding component are opposite to those in Example 3. Thering body 32 of the tablet-holdingcomponent 42 forms anopening 321 for insertion of a medicinal tablet, the opening opens toward the incisors in the horizontal direction formed by the molars and the incisors, and the medicinal tablet is inserted from the incisors to the molars in the horizontal direction. The medicinal tablet may be a controlled-release preparation, preferably an osmotic pump tablet.
Claims (10)
- An oral retention device, comprising a teeth-fitting component and a tablet-holding component, with the teeth-fitting component connected to the tablet-holding component, wherein the teeth-fitting component is used bridge the teeth in oral cavity and the tablet-holding component can hold at least one medicinal tablet and is used to retain the medicinal tablet in oral cavity.
- The oral retention device as defined in claim 1, wherein the teeth-fitting component and the tablet-holding component are connected on respective sides; and/or the tablet-holding component has a reticular structure or a non-reticular structure, and the tablet-holding component has a cross section in the shape of a circular, elliptical, polygonal, or special-shaped closed ring or open ring structure;preferably, the tablet-holding component comprises at least one ring body and at least one retainer, or the tablet-holding component is constituted by at least one retainer; wherein the ring body has an opening for insertion of a medicinal tablet, and the retainer has a structure for limiting the medicinal tablet in the tablet-holding component;more preferably, the opening faces the molars in a horizontal direction formed by the molars and the incisors, and is used to enable the medicinal tablet to be inserted from the molars toward the incisors in the horizontal direction; or the opening is provided in a direction perpendicular to the horizontal direction such that the medicinal tablet is inserted down from the above in the direction perpendicular to the horizontal direction; or the opening faces the buccal side in a direction perpendicular to the horizontal direction such that the medicinal tablet is inserted from the buccal side to the lingual side in the direction perpendicular to the horizontal direction.
- The oral retention device as defined in claim 2, wherein the medicinal tablet is an osmotic pump tablet; and preferably, the osmotic pump tablet contains an active pharmaceutical ingredient and excipients, the active pharmaceutical ingredient is one or more of levodopa or its ester, carbidopa, baclofen, acyclovir, valaciclovir, ganciclovir, metformin, and gabapentin, or one or two of levodopa or its ester and carbidopa.
- The oral retention device as defined in claim 2, wherein the ring body is an open ring body or a closed ring body; and preferably, the ring body is a circular, elliptical, polygonal, or special-shaped closed ring body or open ring body.
- The oral retention device as defined in claim 2, wherein the retainer is of a circular arc hollow or solid shape, or the retainer is formed by connecting a closed ring body and a semicircular part perpendicular to the closed ring body; and/or the retainer abuts with the ring body, or the retainer and the ring body are arranged at an interval; and preferably, the retainer and the ring body are abutted by means of integral molding or are connected together by a connecting structure.
- The oral retention device as defined in claim 2, wherein the retainer is provided as one retainer that is located on the incisor side in the horizontal direction formed by the molars and the incisors; and/or the ring body is provided as one ring body that is located on the molar side in the horizontal direction formed by the molars and the incisors.
- The oral retention device as defined in claim 1, wherein the teeth-fitting component can match with any one or more teeth in oral cavity, and/or the teeth-fitting component has a length equal to the length of 2-5 teeth; and preferably, the teeth are mandibular permanent teeth, preferably mandibular molars, and more preferably the first molar and the second molar, or the first molar, the second molar and the second premolar, or the first molar, the second molar and the third molar, or the first molar, the second molar, the third molar and the second premolar on the mandible.
- The oral retention device as defined in claim 1, wherein the teeth-fitting component is wrapped, embedded, fitted, or inserted into the teeth that matches with the teeth-fitting component.
- The oral retention device as defined in any one of claims 1-8, wherein the material of the oral retention device is an oral stable material, which is selected from oral stable metal or thermoplastic elastomer;preferably, the oral stable metal is one of titanium, stainless steel, cobalt-chromium alloy, cobalt-chromium-molybdenum alloy or precious metal for dental use, and the thermoplastic elastomer is one or two copolymers selected from polycaprolactone, ethylene-vinyl acetate copolymer, high-density polyethylene, polypropylene, polyacrylate, polyurethane, silicon polymer, polyester, poly(styrene-ethylene-butylene-styrene), poly(styrene-butadiene-styrene), and poly(styrene-isoprene-styrene); andmore preferably, the materials of the teeth-fitting component and the tablet-holding component are cobalt-chromium alloy.
- A method for preparing the oral retention device as defined in any one of claims 1-9, the method being selected from any one of 3D printing, injection molding or impression molding;wherein the 3D printing comprises the following steps:(1) adding a saved tablet-holding component model, assembling the model with a teeth-fitting component model to form an integrated oral retention device model, and exporting a 3D printable file; wherein the design software is preferably 3 Shape Dental System,(2) importing the 3D printable file into a 3D printer, and printing the oral retention device; wherein the 3D printing preferably uses a laser sintering process;preferably, before the step (1), the following steps are included: (0) in preferable software SolidWorks or ZWSOFT, designing the tablet-holding component model according to the size data of the medicinal tablet, and saving the model; and/or in the design software 3 Shape Dental System, designing the teeth-fitting component model according to the size data of teeth of the subject; andmore preferably, obtaining the size data of the medicinal tablet and/or the dental data of the subject by means of scanning with a scanner, and the dental model is prepared by traditional molding technique, which is preferably a 3Shape TRIOS® scanner;wherein, the injection molding comprises the following steps:(1) preparing a teeth-fitting component model according to a dental model;(2) preparing a tablet-holding component model according to the size of the medicinal tablet;(3) obtaining an oral retention device model integrating the teeth-fitting component and the tablet-holding component; and(4) preparing a personalized oral retention device by means of a traditional injection molding process, whereinpreferably, the dental model is prepared by traditional molding technology, or prepared by obtaining teeth data of a subject via oral scanning technology and printing; andmore preferably, the materials of the teeth-fitting component model, the tablet-holding component model and the oral retention device model are dental wax, and/or the material of the dental model is gypsum or resin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010980311.4A CN114191307A (en) | 2020-09-17 | 2020-09-17 | Oral cavity detention device and preparation method thereof |
PCT/CN2021/119120 WO2022057905A1 (en) | 2020-09-17 | 2021-09-17 | Oral retention device and preparation method therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4215175A1 true EP4215175A1 (en) | 2023-07-26 |
EP4215175A4 EP4215175A4 (en) | 2024-03-06 |
Family
ID=80644724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21868727.5A Pending EP4215175A4 (en) | 2020-09-17 | 2021-09-17 | Oral retention device and preparation method therefor |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4215175A4 (en) |
JP (1) | JP2023541319A (en) |
CN (2) | CN114191307A (en) |
WO (1) | WO2022057905A1 (en) |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4167558A (en) | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
GB1524740A (en) | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
GB1576376A (en) | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
US4434153A (en) | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
DE3431861A1 (en) | 1984-08-30 | 1986-03-13 | Troponwerke GmbH & Co KG, 5000 Köln | PELLET PREPARATION |
US4735804A (en) | 1985-05-10 | 1988-04-05 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
DK179687D0 (en) | 1987-04-08 | 1987-04-08 | Farma Food As | PREPARATION |
US5002772A (en) | 1988-05-31 | 1991-03-26 | Pfizer Inc. | Gastric retention system for controlled drug release |
US5232704A (en) | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5750585A (en) | 1995-04-04 | 1998-05-12 | Purdue Research Foundation | Super absorbent hydrogel foams |
US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
GB9710699D0 (en) | 1997-05-24 | 1997-07-16 | Danbiosyst Uk | Gastro-retentive controlled release system |
DE69828289T2 (en) | 1997-08-11 | 2005-06-02 | Alza Corp., Mountain View | A sustained-release dosage form |
IN186245B (en) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
CA2320900C (en) | 1998-03-19 | 2009-10-27 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
IL133196A0 (en) | 1999-11-29 | 2001-03-19 | Yissum Res Dev Co | Gastroretentive controlled release pharmaceutical dosage forms |
CN1997421A (en) | 2003-02-06 | 2007-07-11 | 安迪·沃尔夫 | Oral devices and methods for controlled drug delivery |
WO2005079752A2 (en) | 2004-02-11 | 2005-09-01 | Rubicon Research Private Limited | Controlled release pharmaceutical compositions with improved bioavailability |
US7097449B2 (en) | 2004-03-04 | 2006-08-29 | Ultradent Products, Inc. | Dental brackets for retaining a medicament-releasing pellet on a tooth and kits including such brackets |
TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
US20150238292A1 (en) * | 2011-04-08 | 2015-08-27 | Innovative Products, Inc. | Dental prosthetic device with remoldable base and medicant delivery system |
ES2957768T3 (en) | 2013-11-05 | 2024-01-25 | Synagile Corp | Continuous delivery of drugs through the mouth |
KR101424763B1 (en) * | 2013-12-31 | 2014-08-01 | 현기봉 | Apparatus for providing oral medicines |
CN112118886B (en) * | 2018-05-23 | 2022-08-23 | 上海汉都医药科技有限公司 | Controlled release system for active pharmaceutical ingredients and method for preparing same |
CN212973560U (en) * | 2020-09-17 | 2021-04-16 | 上海汉都医药科技有限公司 | Oral cavity detention device |
-
2020
- 2020-09-17 CN CN202010980311.4A patent/CN114191307A/en active Pending
-
2021
- 2021-09-17 JP JP2023517740A patent/JP2023541319A/en active Pending
- 2021-09-17 EP EP21868727.5A patent/EP4215175A4/en active Pending
- 2021-09-17 CN CN202180064047.2A patent/CN116322602A/en active Pending
- 2021-09-17 WO PCT/CN2021/119120 patent/WO2022057905A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN114191307A (en) | 2022-03-18 |
CN116322602A (en) | 2023-06-23 |
WO2022057905A1 (en) | 2022-03-24 |
EP4215175A4 (en) | 2024-03-06 |
JP2023541319A (en) | 2023-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hu et al. | Using intraoral scanning technology for three‐dimensional printing of kennedy class i removable partial denture metal framework: A clinical report | |
JP7125791B2 (en) | Controlled release system for active drug ingredient and method for manufacturing same | |
US20190358000A1 (en) | Tray appliance system for making a dental prosthesis | |
KR102280258B1 (en) | crown for deciduous tooth | |
CN110200718A (en) | With the production method of the integrally formed body retention system of artificial crown and cooperation key way | |
Graf et al. | Direct printed removable appliances: A new approach for the Twin-block appliance | |
Yenisey et al. | A prosthodontic management alternative for scleroderma patients | |
EP4215175A1 (en) | Oral retention device and preparation method therefor | |
CN212973560U (en) | Oral cavity detention device | |
US11911513B2 (en) | Controlled-release system of active pharmaceutical ingredient and preparation method therefor | |
JP2018068628A (en) | Denture | |
JP4546572B1 (en) | Artificial molar | |
Lee et al. | Application and consideration of digital technology for removable complete denture | |
Yoon et al. | Full mouth rehabilitation of a severely worn dentition using intraoral scanner and the CAD/CAM double scanning technique | |
Zhang et al. | Digital workflow for a scleroderma patient with microstomia: A clinical report | |
Vig | Splinting bars and maxillary indirect retainers for removable partial dentures | |
CN216221738U (en) | Oral device with container | |
Hasanzade | Prosthetic rehabilitation of an edentulous patient with microstomia using digital and conventional methods; A case report | |
Jang et al. | Fabrication of closed hollow obturator for hard palate defect patient undergone maxillectomy | |
EP4154847A1 (en) | Method for providing dental mouthpiece having space for drug and method for using same | |
Alkhodary | Effect of digital and conventional workflows on complete denture retention | |
Stavreva | Comparison of digital and conventional impression technique in aspect of procedure, time and satisfaction | |
Abozaed | Clinical Comparative Study of Retention for Single Versus Two-Implant Mandibular Overdentures Reinforced by PEEK Framework | |
Abozaed | AL-AZHAR | |
Ljubičić et al. | Implant-supported single zirconia crowns for posterior teeth using completely digital work-flow: A case report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230414 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20240202 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61J 7/00 20060101AFI20240129BHEP |